Kurse werden geladen...
Prognose
Für dieses Unternehmen liegen uns keine Analysten-Daten vor.
Scoring-Modelle
Für dieses Unternehmen liegen uns bisher keine Scoring-Modelle vor.
News
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PULM and ENTO on Behalf of Shareholders
NEW YORK, NY / ACCESSWIRE / November 15, 2024 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Pulmatrix, Inc. (NASDAQ:PULM)'s merger with Cullgen Inc. Upon closing of the proposed transaction, Pulmatrix stockholders are expected to own approximately 3.6% of the combined company. If you are a Pulmatrix shareholder, click here to learn more about your rights and options.» Mehr auf accesswire.com
PULMATRIX INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Pulmatrix, Inc. - PULM
NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed merger of Pulmatrix, Inc. (NasdaqCM: PULM) and Cullgen Inc. Pursuant to the terms of the agreement, upon completion of the Merger, Pulmatrix stockholders are expected to own approximately 3.6% of the combined company. KSF is seeking to determine whether the merger and the process that led to it are adequate, or whethe.» Mehr auf businesswire.com
PULM INVESTOR ALERT: Rigrodsky Law, P.A. Is Investigating Pulmatrix, Inc. Merger
WILMINGTON, DE / ACCESSWIRE / November 14, 2024 / Rigrodsky Law, P.A. is investigating Pulmatrix, Inc. ("Pulmatrix") (NASDAQ CM:PULM) regarding possible breaches of fiduciary duties and other violations of law related to Pulmatrix's agreement to merge with Cullgen Inc. To learn more about this investigation and your rights, visit: https://www.rl-legal.com/cases-pulmatrix-inc.» Mehr auf accesswire.com
Unternehmenszahlen
(EUR) | Sep. 2024 | |
---|---|---|
Umsatz | 328,65k | 80,15% |
Bruttoeinkommen | 328,65k | 73,78% |
Nettoeinkommen | −2,32 Mio | 34,84% |
EBITDA | −2,39 Mio | 28,10% |
Fundamentaldaten
Metrik | Wert |
---|---|
Marktkapitalisierung | 21,45 Mio€ |
Anzahl Aktien | 3,65 Mio |
52 Wochen-Hoch/Tief | 8,11€ - 1,49€ |
Dividenden | Nein |
Beta | 0,99 |
KGV (PE Ratio) | −2,31 |
KGWV (PEG Ratio) | −0,21 |
KBV (PB Ratio) | 2,04 |
KUV (PS Ratio) | 2,23 |
Unternehmensprofil
Name | Pulmatrix |
CEO | Peter Ludlum CMA, MBA |
Website | |
Mitarbeiter | 22 |
Ticker Symbole
Börse | Symbol |
---|---|
NASDAQ | PULM |
Assets entdecken
Shareholder von Pulmatrix investieren auch in folgende Assets